- Total income
- ₹938 Cr
- Profit
- ₹28 Cr
About Boston Scientific
Boston Scientific is a publicly listed company based in Marlborough (United States) founded in 1979. Wide range of medical devices. The company has 53,000 employees. Boston Scientific has completed 58 acquisitions, including Apama Medical, Apollo Endo and Asthmatx. Its website bostonscientific.com draws about 739 thousand monthly visits. Boston Scientific offers products and services including Defibrillators, Pacemakers, and Spinal Cord Stimulators. Its focus areas include Diversified Medical Devices and Devices. Its legal entity is Boston Scientific Corporation. Its competitors include GE Healthcare, Medtronic and CONMED; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 1979 and headquartered in Marlborough, United States, Boston Scientific operates in the medical devices sector. A broad array of products, including catheters, stents, defibrillators, and surgical tools, is developed, manufactured, and marketed globally. These devices address conditions in cardiology, gastroenterology, pulmonology, vascular health, urology, womens health, and chronic pain. Annual revenues reached 12.68 billion in 2022, with net profit at 0.69 billion.
Boston Scientific is ranked #370 on the Fortune MNC 500 India (2026).
Recognitions & Rankings of Boston Scientific
- Headquarters Marlborough, United States
- Employees 53,000
- Stage Public
- SectorsHealthcare
- Website category Health
- Website bostonscientific.com/en-US/home.html
- Social LinkedIn X Facebook Instagram
- Legal Name Boston Scientific Corporation
- Annual Revenue$20.07 B (USD)19.87as on Dec 31, 2025
- Net Profit$2.9 B (USD)56.31as on Dec 31, 2025
- EBITDA$5.44 B (USD)39.32as on Dec 31, 2025
- Latest Funding Round$922.11K (USD), Grant
Dec 2022
- InvestorsBarclays
& 3 more
- Employee Count53,000
- Investments & AcquisitionsApama Medical
& 57 more
Products & Services of Boston Scientific
Boston Scientific offers a comprehensive portfolio of products and services, including Defibrillators, Pacemakers, and Spinal Cord Stimulators.
Devices for treating irregular heart rhythms and preventing cardiac arrest.
Implants that regulate heartbeats for patients with arrhythmias.
Systems to alleviate chronic pain through electrical stimulation.
Funding Insights of Boston Scientific
- Total Rounds 15
- Last Round Grant β $922,113
- First Round $2.79M
(May 2010)
- Investors Count 4
Latest 10 of 15 funding rounds of Boston Scientific with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $922,113 | Grant | β | β | |
| Jan 2021 | $381,709 | Grant | β | β | |
| Oct 2020 | Grant | β | β | ||
| Apr 2020 | $274,370 | Grant | β | β | |
| Jan 2020 | $529,256 | Grant | β | β | |
| Oct 2019 | $399,628 | Grant | β | β | |
| Jan 2019 | $4.2B | Debt – Conventional | β | β | |
| Jan 2019 | Grant | β | β | ||
| Oct 2018 | $137,477 | Grant | β | β | |
| Sep 2018 | $1B | Debt – Conventional | β | β |
4 investors in total: 4 institutional.
Investors in Boston Scientific
Boston Scientific has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Barclays, Wells Fargo and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Diversified financial services are provided across global markets. | 1690 | home.barclays | London, United Kingdom | |
Diverse financial services and online banking are provided to clients. | 1852 | wellsfargo.com | San Francisco, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Boston Scientific
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Boston Scientific
1150 people are tracked at Boston Scientific (315 in leadership, 9 in board & advisors, 826 in team); the tracked headcount is 53,000.
| Name | Role | Group |
|---|---|---|
Augusto Chaves | IT PMO & Finance Head | Leadership |
Genevieve Morrison | IT Director, Acquisition & Integrations | Leadership |
David Sapienza | VP Global Operation Distribution And Logistics | Leadership |
Nikunj Murgai | Director, IT | Leadership |
Jodi Eddy | Senior Vice President, Enterprise Services and Digital Officer | Leadership |
Siri Thompson | Vice President, Program Management LAAC | Leadership |
Lance Bates | SVP & President, Interventional Cardiology Therapies | Leadership |
Alex Pflugfelder | Director - Upstream EP Marketing, EP Commercial Development Team | Leadership |
Sofía Leiva | HR Specialist - People Services Partner Latam | Leadership |
Zoe Heuver | Supply Chain Partner | Leadership |
Charles K. | Director, Quality | Leadership |
Ahmed Abdelaal | Chief Medical Officer | Leadership |
Lillian Kerrigan | Director Global Quality Design Controls And Acquisitions | Leadership |
Viktoriya Skuz | People Partner I | Leadership |
Kelly Schwenn | Director Of Program Management, Arden Hills And North America Manufacturing | Leadership |
Charudatta Aradhye | Associate Director, R&D | Leadership |
Sandra Nagale | Director, Digital Health Products, Platforms & AI | Leadership |
Gary Leblanc | Director Of Quality | Leadership |
Janet Bukovcan | Director, Regulatory Affairs | Leadership |
Philip Sinclair | Vice President, Global Medical Affairs And Clinical Development, Interventional Oncology | Leadership |
1130 more people are available in the full profile.
Complete people profiles for Boston Scientific
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Boston Scientific
Boston Scientific is a publicly listed company on the NYSE with ticker symbol BSX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 May 1992
- Listed onNYSE: BSX
- Listed entityBoston Scientific Corporation
- Exchange sectorHealth technology
- ISINUS1011371077
- Share price$43.31 (-1.21% on the day) · 2026-10-13
- Market capitalisation$62.77B
- Price to earnings17.6
- EPS (diluted, trailing year)$2.47
- Volume (last session)14,275,650
Financials of Boston Scientific
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $20.07B | $2.90B | $5.44B |
| 2024 | $16.75B | $1.85B | $3.90B |
| 2023 | $14.24B | $1.59B | $3.38B |
| 2022 | $12.68B | $698.0M | $2.96B |
| 2021 | $11.89B | $1.04B | $3.02B |
Detailed financial statements for Boston Scientific
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Boston Scientific
Boston Scientific has strategically engaged in corporate development activities, having acquired 58 companies. Notable acquisitions include Apama Medical, Apollo Endo and Asthmatx.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Penumbra Inc is focused on innovating healthcare technologies globally. | penumbrainc.com | Alameda, United States | 2004 | Jan 2026 | β’β’β’β’ | |
A coin-sized neuromodulation device for hypertension treatment is developed. | valenciatechnologies.com | Santa Clarita, United States | 2011 | Jan 2026 | β’β’β’β’ | |
Developer of a neurostimulation system for managing intractable chronic pain | nalumed.com | Carlsbad, United States | 2014 | Oct 2025 | $533M | |
A denervation catheter for pulmonary hypertension treatment is developed. | sonivie.com | Rosh Haayin, Israel | 2014 | Mar 2025 | $360M | |
Intravascular lithotripsy systems are developed for cardiovascular disease treatment. | boltmed.com | Carlsbad, United States | 2019 | Jan 2025 | β’β’β’β’ | |
Hepatic artery infusion therapy is developed for cancer treatment. | interaoncology.com | Wellesley, United States | 2019 | Nov 2024 | β’β’β’β’ | |
Cortex is focused on transforming atrial arrhythmia diagnosis and treatment. | cortexep.com | Santa Clara, United States | 2023 | Nov 2024 | β’β’β’β’ | |
Provider of neuroprotection devices for carotid artery disease | silkroadmed.com | Sunnyvale, United States | 2007 | Jun 2024 | $1.16B | |
Sacral neuromodulation devices are developed for urinary and bowel control. | axonics.com | Irvine, United States | 2013 | Jan 2024 | $3.7B | |
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain | relievant.com | Redwood, United States | 2004 | Sep 2023 | $850M |
Complete acquisition details for Boston Scientific
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Boston Scientific
14 dated milestones of Boston Scientific across 47 years, from founding to its latest funding, stage changes and deals.
- Founded Boston Scientific is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.8M.
- Funding Latest funding round, Grant, of $922K.
- Acquisition Acquires Relievant Medsystems.
- Acquisition Acquires Axonics.
- Acquisition Acquires Silk Road Medical.
- Acquisition Acquires Cortex.
- Acquisition Acquires Intera Oncology.
- Acquisition Acquires Bolt Med.
- Acquisition Acquires SoniVie.
- Acquisition Acquires Nalu Medical.
- Acquisition Acquires Valencia Technologies.
- Acquisition Acquires Penumbra Inc.
Competitors of Boston Scientific
Boston Scientific has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and CONMED.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| medtronic.com | 1949 | Minneapolis, United States | 1,114 | Medical equipment for treating over 30 chronic diseases is developed. | ||
| conmed.com | 1987 | Utica, United States | 4,100 | Surgical instruments are manufactured for multiple therapeutic areas. |
Detailed competitors of Boston Scientific
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Boston Scientific
The website of Boston Scientific (bostonscientific.com) receives about 738.5K visits a month and ranks #88,615 among all websites worldwide, #2,519 in Health.
- Monthly visits738.5K
▲ 27.5% vs previous month
- Unique visitors293.4K
per month
- Global rank#88,615
among all websites
- Category rank#2,519
Health · Health
- Bounce rate54%
- Pages per visit2.5
- Average visit1 min 31 sec
- DevicesDesktop 53% Β· Mobile 47%
Websites whose visitors overlap most with Boston Scientific. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medtronic.com | 100% | 2.6M | #22,622 | View details | |
| sjm.com | 77% | 1.2K | #13,629,967 | View details | |
| abbott.com | 74% | 917.2K | #65,577 | View details | |
| cookmedical.com | 69% | #429,169 | View details | ||
controlyourpain.com | controlyourpain.com | 69% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Boston Scientific
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Boston Scientific (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 | ||
Diagnostic and surgical products for women's healthcare are provided. | 1985 | Marlborough, Massachusetts, United States | USD 4.1 B | 7,060 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Boston Scientific
Complete news archive for Boston Scientific
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boston Scientific
Boston Scientific was founded in 1979 and raised its 1st funding round 31 years after it was founded.
Boston Scientific is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Boston Scientific has 53,000 employees.
Annual revenue of Boston Scientific is $20.07B as on Dec 31, 2025.
Founded in 1979 and headquartered in Marlborough, United States, Boston Scientific operates in the medical devices sector. A broad array of products, including catheters, stents, defibrillators, and surgical tools, is developed, manufactured, and marketed globally. These devices address conditions in cardiology, gastroenterology, pulmonology, vascular health, urology, womens health, and chronic pain. Annual revenues reached 12.68 billion in 2022, with net profit at 0.69 billion.
Boston Scientific's top competitors include GE Healthcare, Medtronic and CONMED.
Boston Scientific offers Defibrillators, Pacemakers, and Spinal Cord Stimulators.
Yes, Boston Scientific is publicly traded on NYSE under the ticker symbol BSX.
Boston Scientific has made 58 acquisitions, including Apama Medical, Apollo Endo, and Asthmatx.
Boston Scientific has 4 investors. Key investors include Barclays, Wells Fargo, HHS, and European Union.
Boston Scientific operates through Boston Scientific Corporation.
The website of Boston Scientific receives about 739 thousand visits a month and ranks #88,615 among all websites worldwide.

